Medicare Enrolled

Dr. Mauree Whitaker, FNP-BC

Nurse Practitioner - Family · Bishop, GA
Low-engagement
1250 OVERLOOK RIDGE RD, Bishop, GA 30621
7062071166
In practice since 2011 (15 years)
NPI: 1619262946 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Whitaker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Whitaker? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Whitaker

Dr. Mauree Whitaker is a nurse practitioner - family in Bishop, GA, with 15 years of NPI registration.

Between the years covered by Open Payments, Dr. Whitaker received a total of $2,762 from 20 pharmaceutical and/or device companies across 128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Whitaker is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice $2,762 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,762
Total received (2021-2024)
Avg $690/year across 4 years
Top 12% in GA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
128
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,656 (96.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$105 (3.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,897
2023
$758
2022
$92
2021
$15

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$316
Supernus Pharmaceuticals, Inc.
$309
Janssen Pharmaceuticals, Inc
$250
ABBVIE INC.
$225
Takeda Pharmaceuticals U.S.A., Inc.
$144
Otsuka America Pharmaceutical, Inc.
$140
Neurocrine Biosciences, Inc.
$135
Tris Pharma Inc
$68
Alkermes, Inc.
$59
Lundbeck LLC
$55
Indivior Inc.
$52
Teva Pharmaceuticals USA, Inc.
$37
Corium, LLC
$34
Axsome Therapeutics, Inc.
$27
Tempus AI, Inc
$23
Noven Therapeutics, LLC
$23
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2021-2024) ›
Supernus Pharmaceuticals, Inc.
$374
ABBVIE INC.
$339
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$316
Janssen Pharmaceuticals, Inc
$281
Otsuka America Pharmaceutical, Inc.
$226
Takeda Pharmaceuticals U.S.A., Inc.
$220
Alkermes, Inc.
$156
Neurocrine Biosciences, Inc.
$135
Bayer Healthcare Pharmaceuticals Inc.
$120
Lundbeck LLC
$98
ITI, Inc.
$90
Teva Pharmaceuticals USA, Inc.
$84
Tris Pharma Inc
$81
Xeris Pharmaceuticals, Inc.
$61
Indivior Inc.
$52
Corium, LLC
$40
Axsome Therapeutics, Inc.
$27
Tempus AI, Inc
$23
Noven Therapeutics, LLC
$23
McKesson Medical-Surgical, Inc.
$15
Top 3 companies account for 37.3% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ARISTADA · AUSTEDO · Austedo XR · Auvelity · Azstarys · CAPLYTA · Dyanavel XR · GVOKE PFS · INGREZZA · Kerendia · LYBALVI · PERSERIS · QELBREE · Qelbree · REXULTI · SPRAVATO · SUBLOCADE · TRINTELLIX · UZEDY · VRAYLAR · Vivitrol · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nurse practitioner - family in Bishop?
Compare family nurse practitioners in the Bishop area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
362
Per 100K population
846.0
County median income
$115,925
Nearest hospital
ST MARY'S HOSPITAL
10.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Whitaker is a nurse practitioner - family, with low-engagement industry engagement in the top 12% of GA peers, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Whitaker receive payments from pharmaceutical companies?
Yes. Dr. Whitaker received a total of $2,762 from 20 companies across 128 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Whitaker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →